Treatment of Unstable Angina
Patients with unstable angina should be treated with 75 mg of aspirin daily for 18 months, followed by long-term aspirin therapy according to stable angina recommendations. 1
Initial Pharmacological Management
First-Line Medications
Antiplatelet Therapy
Beta-Blockers
- Short-acting beta-selective blockers without intrinsic sympathomimetic activity, initially intravenously in hemodynamically stable patients 1
- Oral beta-blockers can be substituted later or started promptly without prior IV administration 1
- Delay beta-blocker initiation if patient has heart failure or shock until stabilization 1
Nitrates
Second-Line/Additional Medications
Calcium Channel Blockers
ACE Inhibitors
- Add if hypertension persists, if patient has LV dysfunction/heart failure, anterior MI, or diabetes 1
Lipid-Lowering Therapy
- Statin therapy to reduce LDL cholesterol 1
Risk Stratification and Management Algorithm
High-Risk Features (Requiring Aggressive Management)
- Recurrent ischemia (chest pain or dynamic ST changes)
- Elevated troponin levels
- Hemodynamic instability
- Major arrhythmias
- Early post-infarction unstable angina 1
Management Based on Risk
High-Risk Patients:
- Add GP IIb/IIIa receptor blocker
- Perform coronary angiography during initial hospitalization
- Consider revascularization (PCI or CABG) based on coronary anatomy 1
Lower-Risk Patients:
- Continue medical therapy with aspirin, beta-blockers, nitrates
- Consider non-invasive testing to assess for inducible ischemia
Duration of Therapy
- Aspirin: 75 mg daily for 18 months, then continue long-term at 75 mg daily 1
- Beta-blockers: Continue indefinitely in patients with prior MI or ongoing symptoms 1
- Nitrates: Ensure a daily "nitrate-free" interval of 10-12 hours to prevent tolerance 4
- For isosorbide mononitrate (ISMN), typical dosages are 20 mg twice daily (standard) or 60-240 mg once daily (slow-release) 4
Important Considerations and Pitfalls
Medication Cautions
- Nitrates: Avoid concomitant use with phosphodiesterase inhibitors (sildenafil, tadalafil, vardenafil) due to risk of profound hypotension 4
- Blood Pressure Management: Target BP <130/80 mmHg, but lower DBP slowly and cautiously, especially in older patients with wide pulse pressures 1
- Clopidogrel: Effectiveness may be reduced in patients who are CYP2C19 poor metabolizers; avoid concomitant use with omeprazole or esomeprazole 2
Common Pitfalls
- Nitrate Tolerance: Failing to implement a nitrate-free interval, which reduces effectiveness 4
- Underuse of Beta-Blockers: These are cornerstone therapy but are often underutilized 1
- Inadequate Antiplatelet Therapy: Aspirin significantly reduces risk of subsequent vascular events (NNT of 15) 1
- Overlooking Comorbidities: Diabetes, hypertension, and heart failure require specific medication considerations 1
The evidence strongly supports that early and aggressive medical therapy significantly reduces the risk of progression to myocardial infarction or death in patients with unstable angina, with aspirin showing particularly strong benefits in reducing subsequent vascular events.